Shopping Cart
- Remove All
- Your shopping cart is currently empty
Vibostolimab is a monoclonal antibody against T cell immune proteins and the ITIM domain.Vibostolimab has shown anti-tumor activity in in vitro trials and can be used to study non-small cell lung cancer (NSCLC) and melanoma.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $228 | In Stock | |
5 mg | $578 | In Stock | |
10 mg | $928 | In Stock |
Description | Vibostolimab is a monoclonal antibody against T cell immune proteins and the ITIM domain.Vibostolimab has shown anti-tumor activity in in vitro trials and can be used to study non-small cell lung cancer (NSCLC) and melanoma. |
In vitro | Binding to TIGIT and blocking the interaction between TIGIT and its ligands (CD112 and CD155), Vibostolimab activates T lymphocytes, aiding in the destruction of tumor cells[1]. |
Alias | Vibostolimab (anti-TIGIT) |
Molecular Weight | 147.08 kDa |
Cas No. | 2231305-30-7 |
Storage | store at low temperature | store at -80°C | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.